[1] 王吉耀,廖二元,黄从新,等. 肝性脑病. 内科学. 人民卫生出版社. 2010年8月第2版:541-548.
[2] 中华医学会传染病与寄生虫病学分会、肝病学分会联合修订. 病毒性肝炎防治方案. 中华传染病杂志, 2001, 19: 56-62.
[3] Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the Working Party at the 11th World Congresses of Gastroenterology. Vienna, 1998. Hepatology, 2002, 35: 716-721.
[4] Karvellas CJ, Pink F, Mcphail M, et al. Bacteremia, acutephysiology and chronic health evaluation II and modified end stage liver disease are independent predictors of mortality in critically ill nontransplanted patients with acute on chronic liver failure. Critical care medicine, 2010, 38:121-126.
[5] Shawcross DL, Wright GA, Stadlbauer V, et al. Ammonia impairs neutrophil phagocytic function in liver disease. Hepatology, 2008, 48: 1202-1212.
[6] Lin CY, Tsai IF, Ho YP, et al. Endotoxemia contributes to the immune paralysis in patients with cirrhosis. J Hepatol, 2007, 46: 816-826.
[7] Teltschik Z, Wiest R, Beisner J, et al. Intestinal bacterial translocation in rats with cirrhosis is related to compromised Paneth cell antimicrobial host defense. Hepatology, 2012, 55: 1154-1163.
[8] Tranah TH, Vijay GK, Ryan JM, et al. Systemic in ammation and ammonia in hepatic encephalopathy. Metab Brain Dis, 2013, 28: 1-5.
[9] Pijls KE, Jonkers DM, Elamin EE, et al. Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature. Liver Int, 2013, 33: 1457-1469. |
